Lactate and redox status in malignant tumors;Laktat und redoxstatus in malignen tumoren

Anaesthesist

Volumn 56, Issue 5, 2007, Pages 466-469

  Sattler, U G A ^a   Walenta, S ^a   Mueller Klieser, W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bioluminescence imaging; Lactate; Pyruvate; Redox status; Tumor metabolism

Indexed keywords

LACTIC ACID; PYRUVIC ACID; SCAVENGER;

ARTICLE; BIOLUMINESCENCE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CARBOHYDRATE METABOLISM; GLYCOLYSIS; HEAD AND NECK CARCINOMA; LACTATE BLOOD LEVEL; OXIDATION REDUCTION REACTION; RECTUM CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

CARBOHYDRATE METABOLISM; FREE RADICAL SCAVENGERS; GLYCOLYSIS; HUMANS; LACTATES; LUMINESCENCE; NEOPLASMS; OXIDATION-REDUCTION; PYRUVIC ACID;

EID: 34347397403     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1164-2     Document Type: Article

References (22)

1. Brand K (1997) Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomemb 29(4): 355-364
2. Brizel DM, Schroeder T, Scher RL et al. (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51(2): 349-353
3. Dooley CT, Dore TM, Hanson GT et al. (2004) Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem 279(21): 22284-22293
4. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11): 891-899
5. Gottfried E, Kunz-Schughart LA, Ebner S et al. (2006) Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107(5): 2013-2021
6. Groussard C, Morel I, Chevanne M et al. (2000) Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. J Appl Physiol 89(1): 169-175
7. Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4): 266-276
8. Hoffmann A, Gloe T, Pohl U (2001) Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J Cell Physiol 188(1): 33-44
9. Keul J, Doll E, Keppler D (1972) Medicine and sport science, Bd 7. Energy metabolism of human muscle. Karger, Basel
10. Larsen E, Reite K, Nesse G et al. (2006) Repair and mutagenesis at oxidized DNA lesions in the developing brain of wild-type and Ogg1-/-mice. Oncogene 25(17): 2425-2432
11. Lin X, Zhang F, Bradbury CM et al. (2003) 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res 63(12): 3413-3417
12. Mitka M (2005) Diabetic retinopathy mechanism probed. JAMA 293(2): 148-149
13. Mueller-Klieser W, Walenta S (1993) Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 25(6): 407-420
14. O'Donnell-Tormey J, Nathan CF, Lanks K et al. (1987) Secretion of pyruvate. An antioxidant defense of mammalian cells. J Exp Med 165(2): 500-514
15. Quennet V, Yaromina A, Zips D et al. (2006) Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother Oncol 81(2): 130-135
16. Salahudeen AK, Clark EC, Nath KA (1991) Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest 88(6): 1886-1893
17. Sattler UG, Walenta S, Mueller-Klieser W (2007) A bioluminescence technique for quantitative and structure-associated imaging of pyruvate. Lab Invest 87(1): 84-92
18. Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8(4) Suppl: S62-67
19. Walenta S, Schroeder T, Mueller-Klieser W (2004) Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 11(16): 2195-2204
20. Walenta S, Wetterling M, Lehrke M et al. (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60(4): 916-921
21. Walenta S, Chau T-V, Schroeder T et al. (2003) Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 129(6): 321-326
22. Yaromina A, Zips D, Thames HD et al. (2006) Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 81(2): 122-129